-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JjhTgFdhfLb0gRbm/Vz7UehODiyrYvZMzYYVeS/fFXU+d+9rgw/5J9Z01+LU9s4J JYBA+MOeamP1V/fW4T0/sA== 0001209191-04-017067.txt : 20040323 0001209191-04-017067.hdr.sgml : 20040323 20040323150153 ACCESSION NUMBER: 0001209191-04-017067 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040322 FILED AS OF DATE: 20040323 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: POST LEONARD E CENTRAL INDEX KEY: 0001235862 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28298 FILM NUMBER: 04684867 BUSINESS ADDRESS: STREET 1: ONYX PHARMACEUTICALS INC STREET 2: 3031 RESARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ONYX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001012140 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943154463 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3031 RESEARCH DR STREET 2: BLDG A CITY: RICHMOND STATE: CA ZIP: 94806 BUSINESS PHONE: 5102229700 MAIL ADDRESS: STREET 1: 3031 RESEARCH DRIVE CITY: RICHMOND STATE: CA ZIP: 94806 4 1 doc4.xml FORM 4 SUBMISSION X0201 4 2004-03-22 0 0001012140 ONYX PHARMACEUTICALS INC ONXX 0001235862 POST LEONARD E C/O ONYX PHARMACEUTICALS, INC. 3031 RESEARCH DR., BLDG. A RICHMOND CA 94806 0 1 0 0 SVP, Research & Development Common Stock 2004-03-22 4 M 0 10000.0000 10.0000 A 24729.0000 D Common Stock 2004-03-22 4 S 0 2400.0000 36.0000 D 22329.0000 D Common Stock 2004-03-22 4 S 0 2800.0000 36.0100 D 19529.0000 D Common Stock 2004-03-22 4 S 0 400.0000 36.0200 D 19129.0000 D Common Stock 2004-03-22 4 S 0 400.0000 36.0300 D 18729.0000 D Common Stock 2004-03-22 4 S 0 4000.0000 36.0400 D 14729.0000 D Stock Option (Right to Buy) 10.0000 2004-03-22 4 M 0 10000.0000 0 D 2001-07-28 2010-07-27 Common Stock 10000.0000 170000.0000 D The shares subject to the option become exercisable at a rate of 25% on the first anniversary of the date of grant and in equal monthly amounts thereafter for the following 36 months. /s/ Gregory Giotta, Attorney-in-fact 2004-03-23 -----END PRIVACY-ENHANCED MESSAGE-----